| Product Code: ETC067003 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India Non-Oncology Precision Medicine Market was estimated at USD 772 Million in 2025 and is projected to reach USD 1100 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This upward trajectory can largely be attributed to the alarming rise in chronic diseases across the nation, coupled with a growing consumer awareness around personalized healthcare options. Moreover, substantial investments by both public and private sectors are enhancing the accessibility and innovation in treatment modalities.
The India Non-Oncology Precision Medicine market experienced a notable rebound starting in 2022, achieving growth of 8.8% after a slight decline of 3.5% in 2021. Factors contributing to this resurgence include increased consumer demand for personalized healthcare solutions and significant investments in technology and infrastructure. The market is expected to maintain a robust growth rate of approximately 7.5% to 7.6% through 2025, driven by advancements in diagnostics and data analytics. However, as we look toward 2028 and beyond, a slight deceleration to around 6.1% can be anticipated, primarily due to market saturation and evolving regulatory landscapes. Overall, the trend is upward, reflecting the evolving dynamics in healthcare innovation.
This graph highlights how the India Non-Oncology Precision Medicine Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.5% | Growing urbanization and commercial development |
| 2022 | 8.8% | Growing renewable energy integration projects |
| 2023 | 7.5% | Increasing industrial infrastructure investments |
| 2024 | 7.6% | Expansion of manufacturing activities |
| 2025 | 7.5% | Expansion of manufacturing activities |
| 2026 | 7.4% | Growing urbanization and commercial development |
| 2027 | 6.4% | Increasing industrial infrastructure investments |
| 2028 | 6.1% | Increasing industrial automation investments |
| 2029 | 6.1% | Increasing adoption of advanced technologies |
| 2030 | 6.4% | Rapid growth in telecom and data center sectors |
| 2031 | 6.1% | Government infrastructure modernization initiatives |
| 2032 | 6.7% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The increasing prevalence of chronic diseases is currently the most influential force driving the India Non-Oncology Precision Medicine Market. As nearly 60% of deaths in the country are attributed to chronic ailments like cardiovascular disorders, diabetes, and hypertension, the need for tailored medical solutions has never been more critical.
Additionally, advancements in molecular diagnostics and genomics are reshaping the landscape. These technologies enable healthcare providers to offer more precise and personalized treatment options, leading to improved patient outcomes and a growing acceptance of non-oncology precision medicine among both practitioners and patients.
Despite the growth potential, several constraints hinder market expansion. One significant barrier is the high cost associated with non-oncology precision medicine, which can restrict access for economically disadvantaged groups. In addition, the lack of trained professionals proficient in modern diagnostic technologies presents another challenge. The existing training infrastructure has not kept pace with the rapid technological advancements, resulting in a shortage of skilled personnel. Lastly, regulatory hurdles complicate the introduction of novel treatments, further delaying access to essential healthcare innovations.
Emerging trends within the India Non-Oncology Precision Medicine Market include a shift towards more integrated healthcare solutions that emphasize holistic patient care. There is a growing inclination towards utilizing artificial intelligence in diagnostics and treatment planning, streamlining processes and enhancing accuracy. Additionally, partnerships between technology firms and healthcare providers are fostering innovative approaches to treatment, such as wearable health monitoring devices that allow for real-time patient data collection. Furthermore, awareness campaigns are increasingly educating the population on the benefits of personalized medicine, thereby driving demand.
As the market evolves, numerous growth opportunities are emerging. Investment in health tech startups focusing on personalized medicine is likely to yield significant returns, driven by the increasing demand for targeted therapies. Additionally, there is potential for growth in telemedicine solutions that provide precision medicine consultations remotely, expanding access to healthcare services in rural areas. Lastly, collaborations with international research institutions can enhance local capabilities in genomics and diagnostics, further propelling innovation within the sector.
The Indian government has recognized the importance of enhancing healthcare accessibility and quality through various initiatives. Programs under the National Health Mission aim to improve healthcare services for underserved populations, while the "Healthy India" campaign focuses on preventive care and early diagnosis. Furthermore, increased public spending on health infrastructure is supporting advancements in precision medicine, making treatments more accessible to a broader demographic.
Looking ahead to the period between 2026 and 2032, the India Non-Oncology Precision Medicine Market is positioned for substantial growth. Continued technological advancements, along with a favorable regulatory landscape shaped by government initiatives, are expected to drive market expansion. As more healthcare professionals adopt precision medicine approaches, the model of care will likely evolve towards personalized, patient-centric solutions, making significant strides in tackling chronic disease challenges.
In recent months, the industry has witnessed notable shifts towards digital health solutions, with several initiatives focusing on integrating data analytics into personalized treatment protocols. Additionally, strategic partnerships between technology firms and healthcare providers are on the rise, aiming to leverage artificial intelligence for enhanced diagnostics. Regulatory frameworks are also being updated to facilitate the introduction of innovative therapies, which is expected to streamline processes and improve access to cutting-edge treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Non-Oncology Precision Medicine Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Non-Oncology Precision Medicine Market Revenues & Volume, 2022 & 2032F |
3.3 India Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 India Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 India Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 India Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2022 & 2032F |
4 India Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of precision medicine in non-oncology diseases |
4.2.2 Growing awareness about personalized healthcare solutions |
4.2.3 Technological advancements in genetic testing and molecular diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with precision medicine treatments |
4.3.2 Limited reimbursement policies for precision medicine therapies |
4.3.3 Lack of skilled healthcare professionals for implementing precision medicine approaches |
5 India Non-Oncology Precision Medicine Market Trends |
6 India Non-Oncology Precision Medicine Market, By Types |
6.1 India Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2022-2032F |
6.1.3 India Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2022-2032F |
6.1.4 India Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.1.5 India Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2022-2032F |
6.1.6 India Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2022-2032F |
6.1.7 India Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2022-2032F |
6.2 India Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 India Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2022-2032F |
6.2.3 India Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2022-2032F |
6.2.4 India Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2022-2032F |
7 India Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 India Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 India Non-Oncology Precision Medicine Market Imports from Major Countries |
8 India Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Adoption rate of precision medicine in non-oncology diseases |
8.2 Number of partnerships between healthcare providers and precision medicine companies |
8.3 Patient outcomes and quality of life improvements post-precision medicine treatments |
9 India Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 India Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 India Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2022 & 2032F |
10 India Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 India Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2025 |
10.2 India Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here